Author Archive for Insider Scoop

AMD, Marvell Gain Semiconductor Share In Q3

Courtesy of Benzinga.

AMD, Marvell Gain Semiconductor Share In Q3

Susquehanna just released its quarterly report on the semiconductor industry, and the latest numbers indicate Advanced Micro Devices, Inc. (NASDAQ: AMD) and Marvell Technology Group Ltd (NASDAQ: MRVL) have been the two big winners of the past quarter.

Susquehanna’s PC-SIGnals report analyzes data from thousands of desktops, laptops, GPUs and SSDs to track semiconductor industry trends.

According to analyst Christopher Rolland, AMD’s Vega release resulted in a 4-percent quarter-over-quarter GPU share gain. In addition, Vega has triggered an uptick in GPU average sales price, which was up as much as 25 percent on the quarter. AMD was also able to gain CPU share in the third quarter.

At the same time, laptop SSD attach rates surged to new all-time highs of around 56 percent, despite NAND shortages. Marvell was the big share gainer in the space, picking up 2 percent of SSD market share in the third quarter.

Rolland said AMD’s share gains came at the expense of NVIDIA Corporation (NASDAQ: NVDA). Rolland said Intel Corporation (NASDAQ: INTC), on the other hand, could be a winner from rising ASPs.

“Intel should benefit as 3Q17 ASPs rise and as our ODM notebook tracker offers upside, now suggesting low-single-digit unit growth in 2017,” Rolland wrote.

ODM notebook sales are coming in better than expected in the third quarter, up 7.2 percent compares to Q2 and 3.0 percent year over year. Those growth numbers topped Susquehanna’s expectations of 2.6 percent and 0.8 percent, respectively. Surprisingly strong ODM notebook sales is a positive for both AMD and Intel.

In light of the latest semiconductor numbers, Susquehanna prefers investors choose Positive-rated Intel Corporation and Marvell Technology over Neutral-rated AMD and Nvidia.

Related Link: 5 Reasons To Invest In Semiconductors,
continue reading

What’s Up With Sprint And T-Mobile?

Courtesy of Benzinga.

What's Up With Sprint And T-Mobile?

Shares of Sprint Corp (NYSE: S) rose more than 7 percent Tuesday morning while shares of T-Mobile US Inc (NASDAQ: TMUS) gained 5 percent after CNBC’s David Faber reported the two mobile companies are in active merger talks.

Sprint along with its parent company Softbank and T-Mobile and its parent company Deutsche Telekom could be weeks away from finalizing an agreement that would merge the two companies together, Faber suggested. The deal may consist of a stock-for-stock merger under which T-Mobile’s parent company, Deutsche Telekom, will become the majority owner.

As is always the case, the chances of a deal finalizing are not guaranteed, Faber continued. The two companies were engaged in “meaningful” talks earlier this year at which point Softbank was open to the idea of selling its stake. However, this time around, Softbank is demanding to remain a significant, although still minority shareholder in the combined entity.

A merger of the two companies could generate billions of dollars’ worth of cost synergies and savings and see John Legere, T-Mobile’s current CEO, lead the combined entity. But Softbank’s CEO Masayoshi Son is still demanding a say in the company’s direction, which may add a layer of complexity to the already difficult talks.

Finally, the biggest obstacle to any deal would come from government regulators, Faber concluded. The merger of Sprint and T-Mobile would combine the number three and number four wireless carriers into one company and it is not clear if the Department of Justice would sign off on such a deal.

Related Links:

Sprint And T-Mobile Surge Following Merger Rumors; Talks Expected To Begin In April

T-Mobile To Bundle Netflix Subscription With New Family Plans

Posted-In: David Faber Deutsche TelekomCNBC News M&A Movers Tech Media Best of Benzinga

Analyst ‘Takes A Flyer’ On McKesson, Upgrades Ahead Of Earnings

Courtesy of Benzinga.

Analyst 'Takes A Flyer' On McKesson, Upgrades Ahead Of Earnings

“Taking a flyer” on McKesson Corporation (NYSE: MCK), as per its recent assertion that it would take a call at the right time, Baird upgraded shares of the company. The firm noted that the company’s shares have materially underperformed in the year-to-date period as well as the trailing 12-month period, and trade at notable discounts, both on an absolute and relative basis.

As such, the firm upgrades shares of McKesson from Neutral to Outperform and increased its price target from $175 to $178. The firm clarified that the 20-percent upside potential implied by the revised price target presented adequate cushion for a tactical upgrade.

In pre-market trading, shares of McKesson were rallying 3.02 percent to $152.90.

Confidence In 2018

Analyst Eric Coldwell indicated that time the firm spent with McKesson management last week had only limited influence on the call. Based on the meeting, the analyst said management, though it did not provide any quarterly guidance, exuded confidence in 2018 and the company’s long-term vision.

While stating that his visibility into the second quarter of 2018 remains limited, Coldwell also said he believes the September quarter will demonstrably exceed the fiscal first quarter performance (see Coldwell’s track record here).

The analyst thinks the tone and outlook for the December and March quarters will be relatively positive, irrespective of the September outcome.

See also: 4 Reasons You Can Expect Allscripts To Outperform

Upside Risk Returning To Story

Baird noted that buy-side generics procurement has materially improved and sell-side customer pricing is stabilizing. Additionally, brand price inflation guidance and guidance for generics that inflate in value is very modest, and net reimbursement headwinds are likely balancing, the firm added.

The firm believes upside risk is returning to the McKesson story, though believing it might take another quarter or two to present fully. Longer term, the firm still sees material risk for changing dynamics.

Opportunities And Risks

On the…
continue reading

Benzinga’s Top Upgrades, Downgrades For September 18, 2017

Courtesy of Benzinga.

Top Upgrades

  • RBC Capital upgraded Applied Materials, Inc. (NASDAQ: AMAT) from Sector Perform to Outperform. Applied Materials shares gained 0.19 percent to close at $47.14 on Friday.
  • UBS upgraded Caterpillar Inc. (NYSE: CAT) from Neutral to Buy. Caterpillar shares rose 1.51 percent to $123.20 in pre-market trading.
  • William Blair upgraded Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) from Market Perform to Outperform. Arrowhead Pharmaceuticals shares rose 7.88 percent to $3.56 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Platform Specialty Products Corp (NYSE: PAH) from Hold to Buy. Platform Specialty shares gained 2.95 percent to $11.51 in pre-market trading.
  • Piper Jaffray upgraded Precision Drilling Corp (USA) (NYSE: PDS) from Neutral to Overweight. Precision Drilling shares rose 4.53 percent to $3.00 in pre-market trading.
  • Morgan Stanley upgraded Instructure Inc (NYSE: INST) from Equal-Weight to Overweight. Instructure shares rose 1.57 percent to $32.25 in pre-market trading.
  • Analysts at Goldman Sachs upgraded Infosys Ltd ADR (NYSE: INFY) from Sell to Neutral. Infosys shares gained 1.02 percent to $14.80 in pre-market trading.
  • Susquehanna upgraded ASML Holding NV (ADR) (NASDAQ: ASML) from Neutral to Positive. ASML shares rose 1.19 percent to $164.35 in pre-market trading.
  • BMO Capital upgraded BP plc (ADR) (NYSE: BP) from Market Perform to Outperform. BP shares rose 0.16 percent to $36.64 in pre-market trading.
  • Analysts at KeyBanc upgraded MEDNAX Inc (NYSE: MD) from Sector Weight to Overweight. Mednax shares declined 0.33 percent to close at $42.90 on Friday.

Top Downgrades

  • Analysts at Piper Jaffray downgraded Finish Line Inc (NASDAQ: FINL) from Neutral to Underweight. Finish Line shares rose 2.84 percent to close at $10.49 on Friday.
  • DA Davidson downgraded Super Micro Computer, Inc. (NASDAQ: SMCI) from Buy to Neutral. Super Micro Computer shares fell 7.52 percent to close at $23.35 on Friday.
  • Buckingham downgraded United Continental Holdings Inc (NYSE: UAL) from Buy to Neutral. United Continental shares fell 0.50 percent to $59.50 in pre-market trading.
  • Baird downgraded Teladoc Inc (NYSE: TDOC) from Outperform to Neutral. Teladoc shares fell 2.84 percent to close at $35.95 on

continue reading

22 Stocks Moving In Monday’s Pre-Market Session

Courtesy of Benzinga.


  • Nabriva Therapeutics plc (NASDAQ: NBRV) rose 84.4 percent to $12.65 in pre-market trading after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints.
  • Silver Spring Networks Inc (NYSE: SSNI) rose 23.1 percent to $16.00 in pre-market trading. Itron, Inc. (NASDAQ: ITRI) announced plans to acquire Silver Spring Networks for $16.25 per share.
  • Orbital ATK Inc (NYSE: OA) rose 19.5 percent to $131.50 in pre-market trading. Northrop Grumman Corporation (NYSE: NOC) announced plans to acquire Orbital ATK for $7.8 billion in cash.
  • Pluristem Therapeutics Inc. (NASDAQ: PSTI) rose 10.5 percent to $1.48 in pre-market trading after the company disclosed that it has been granted FDA Fast Track Designation for PLX-PAD.
  • BioTime, Inc. (NYSE: BTX) rose 10.2 percent to $3.14 in pre-market trading after the company reported that it has been awarded a $1.56 million grant from the National Institutes of Health.
  • Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) rose 7.9 percent to $3.56 in pre-market trading after surging 18.28 percent on Friday. William Blair upgraded Arrowhead Pharmaceuticals from Market Perform to Outperform.
  • Cogint, Inc. (NASDAQ: COGT) rose 6.3 percent to $5.05 in pre-market trading after falling 4.04 percent on Friday.
  • BlackBerry Ltd (NASDAQ: BBRY) shares rose 6.2 percent to $9.84 in pre-market trading. BlackBerry is expected to release Q2 results on September 28, 2017.
  • BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ: BVXV) rose 5.6 percent to $7.50 in pre-market trading after gaining 1.07 percent on Friday.
  • Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) rose 5.2 percent to $4.66 in pre-market trading after the company reported that it has received a purchase order from Nisshinbo for the development program to advance use of Non Precious Metal Catalyst fuel cells in material handling.
  • NewLink Genetics Corp (NASDAQ: NLNK) shares rose 5.2 percent to $13.33 in pre-market trading after falling 3.94 percent on Friday.
  • Rite Aid Corporation (NYSE: RAD) rose 5 percent to $2.76 in pre-market trading after gaining 5.20 percent on Friday.
  • Pain Therapeutics, Inc. (NASDAQ: PTIE) shares rose 2.9 percent to $4.00 in

continue reading

Papa John’s And Sonic: 2 Appetizing Stocks For Value-Hungry Investors

Courtesy of Benzinga.

Papa John's And Sonic: 2 Appetizing Stocks For Value-Hungry Investors

Analysts at Citigroup identified on Monday two restaurant stocks that could offer value to investors looking to invest in the group. The firm’s Gregory Badishkanian initiated coverage of both Papa John’s Int’l, Inc. (NASDAQ: PZZA) and Sonic Corporation (NASDAQ: SONC) with bullish ratings.

Papa John’s

Badishkanian initiated coverage of Papa John’s stock with a Buy rating and $90 price target. The pizza chain offers investors a differentiated concept through unique advertising campaigns and partnerships. This business model appears to be sustainable over the long term as the company gains market share and grows out its store count.

While bears might argue the domestic promotional environment within the pizza restaurant is reason to avoid the stock, these fears are “overbaked” and represent an attractive entry point for longer-term investors.


Badishkanian initiated coverage of Sonic’s stock with a Buy rating and $28 price target. As the largest drive-in chain in the U.S. with more than 3,500 restaurants across 45 states, the company certainly offers a differentiated concept. On top of that, the company’s proven operating methods, diverse menu, an attractive value proposition and strong management team are all factors that are not included in the stock’s current valuation.

Related Links:

5 Easy Ways To Get A Free (Or At Least Cheaper) Meal

11 Places To Eat Free On Your Birthday

Latest Ratings for PZZA

Date Firm Action From To
Sep 2017 Citigroup Initiates Coverage On Buy
Aug 2017 Stephens & Co. Maintains Overweight
Nov 2016 KeyBanc Downgrades Overweight Sector Weight

View More Analyst Ratings for PZZA

View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Price Target Initiation Restaurants Analyst Ratings Trading Ideas General Best of Benzinga

‘Panic’ May Be Setting In Among Nike Investors

Courtesy of Benzinga.

'Panic' May Be Setting In Among Nike Investors

Nike Inc (NYSE: NKE) investors’ patience for a turnaround may be starting to wane.

“Patience is wearing thin and panic may be setting in,” said Canaccord Genuity analyst Camilo Lyon as he lowered fiscal year 2018 estimates from $2.34 to $2.32.

Since 2015′s all-time highs, shares are down 20 percent and have done very little in the past two years, despite new marketwide highs.

During that time, Nike has shown little promise in pipeline innovation, beyond the VaporMax release, which is one of the few areas doing well for the company.

Meanwhile, adidas (AG) (ADR) (OTC: ADDYY) has taken off in the last two years, with shares tripling as it continues to steal market share away from Nike and in turn cause panic amid Nike investors and the company internally.

During Nike’s fall from grace, discounting products has been widespread, crippling retail partners with weak comps. Demand for some of Nike’s biggest shoe platforms — Jordan, Roshe and signature basketball — have all deteriorated. It will be difficult to overcome the stigma that significant discounting does to a brand.


Heading into Nike’s first-quarter earnings, Lyon echoed the sentiment that expectations will need to be tempered, especially regarding the company’s ambitious target of $50 billion in revenue by 2020. This target was announced in 2015 when things were looking much different for Nike.

“Historically Q1 is NKE’s strongest quarterly beat, and given how seemingly conservative this Q1 sounds (flat sales and GM down 150-180bps), NKE should surprise to the upside due to an optically low bar,” said Lyon.

Lyon expects that the futures and global futures will deteriorate further and expects the discounting to persist into 2018. Canaccord Genuity maintains a Hold rating on Nike with a $51 price target.

Related Link: Finish Line Downgraded Ahead Of Earnings 


Image Credit: image used with permission

Latest Ratings for NKE

Date Firm Action From To
Sep 2017 Bernstein Initiates Coverage On Outperform
Aug 2017 Morgan Stanley Maintains Overweight
Aug 2017 Jefferies Downgrades Buy Hold

View More Analyst Ratings for NKE

View the Latest Analyst Ratings

Posted-In: Analyst Color Earnings News Guidance Previews Reiteration Sports Analyst Ratings Best of Benzinga

Analyst: We’re Downgrading Teladoc, But We Remain Very Bullish

Courtesy of Benzinga.

Analyst: We're Downgrading Teladoc, But We Remain Very Bullish

Analysts at Baird Equity Research no longer consider Teladoc Inc (NYSE: TDOC) to be a stock investors should necessarily be buying, although holders of the stock may not want to sell either. The firm’s Matthew Gillmor downgrades Teladoc’s stock rating from Overweight to Neutral with an unchanged $36 price target.

The downgrade of the telehealth company is not a “negative call,” and the company’s long-term growth potential and strategy remain unchanged, Gillmor commented in his downgrade note (see his track record here). But at the same time, a more than 100-percent gain since the start of 2017 and 62 percent since initiating coverage in March many of the positive developments have mostly played out, including:

    1. Re-accelerating visit utilization.
    2. “Diminishing” noise concerning competitor behavior and pricing.
    3. A compelling valuation relative to its growth prospects.

“As the undisputed leader, with an increasingly broad set of virtual health capabilities (re: Best Doctors, etc.), we think TDOC is well positioned to capture this market opportunity,” Gillmor wrote. “We simply think the stock may take a temporary breather and consolidate recent gains.”

Finally, the stock’s forward revenue multiple has typically fluctuated in a range from 4x to 6x yet the current valuation of 6.3x is still “reasonable,” the analyst concluded. In fact, the current multiple could imply a 20 percent upside based on 2019 numbers.

At time of publication, shares of Teladoc were down 6.26 percent at $33.70.

Related Links:

Analyst On Teladoc Acquisition Of Best Doctors: ‘We Like It’

Teladoc Moves Up The ‘Acuity Food Chain’ With Best Doctors Acquisition

Latest Ratings for TDOC

Date Firm Action From To
Sep 2017 Baird Downgrades Outperform Neutral
May 2017 KeyBanc Initiates Coverage On Overweight
May 2017 Craig-Hallum Downgrades Buy Hold

View More Analyst Ratings for TDOC

View the Latest Analyst Ratings

Posted-In: Analyst Color News Downgrades Health Care Analyst Ratings Movers Tech General Best of Benzinga

7 Takeaways From Apple Investor Meetings Suggest Concern Over Face ID, iPhone X Pricing

Courtesy of Benzinga.

7 Takeaways From Apple Investor Meetings Suggest Concern Over Face ID, iPhone X Pricing

Apple Inc. (NASDAQ: AAPL) investors had their biggest week of the year, with the company finally unveiling its highly-anticipated 10-year anniversary iPhone family of products.

Following the event, KGI analyst Ming-Chi Kuo discussed Apple’s new devices with customers, and she said the jury is still out on the iPhone X, at least until preorders begin on Oct. 27.

In a new note, Kuo outlined seven key takeaways from the event and conversations with customers:

  • 1. The market’s switch from touch ID to facial recognition ID is bad news for companies who produce fingerprint technology.
  • 2. Apple is likely delaying iPhone X preorders because it wants to avoid cannibalizing iPhone 8 and iPhone 8 Plus preorders.
  • 3. Some Apple investors are concerned about sell-through of iPhone 8 and iPhone 8 Plus from Q1 of 2018.
  • 4. Investors expect some profit-taking in Apple suppliers due to concerns over iPhone X demand and pricing.
  • 5. Investors aren’t concerned about the fact that the iPhone X doesn’t come in gold.
  • 6. The Apple Watch Series 3 was an under-the-radar winner from the event, and investors see it as a potential leader in the high-end sports watch market.
  • 7. The fact that Apple announced its AirPower wireless charger but failed to provide specific shipment dates or detailed tech specs for the device supports KGI’s theory that there may be production issues with the device.

For now, Kuo says Apple investors should have Oct. 27 circled on the calendar.

“We see concerns about market acceptance of Face ID and the pricing of iPhone X, before confirmation of robust pre-orders is seen. Therefore, market views may be mixed before pre-orders of iPhone X begin on October 27,” she wrote.

Apple stock finished launch week down 1 percent at $159.88.

Related Link: A Technical Take On Apple’s Volatile iPhone X Launch Day

Latest Ratings for AAPL

Date Firm Action From To
Sep 2017 Nomura Maintains Buy
Aug 2017 Nomura Maintains Buy
Aug 2017 Barclays Maintains Equal-Weight

View More Analyst Ratings for AAPL

View the Latest Analyst Ratings

Posted-In: Apple Watch Series 3 Face ID iPhone iPhone 8 iPhone 8 PlusAnalyst Color Analyst Ratings Tech Best of Benzinga

Earnings Scheduled For September 15, 2017

Courtesy of Benzinga.

Earnings Scheduled For September 15, 2017

Companies Reporting Before The Bell

  • Tsakos Energy Navigation Ltd. (NYSE: TNP) is estimated to report quarterly earnings at $0.05 per share on revenue of $109.98 million.

Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets


Chart School

Minor Changes: Yesterday's and Weekend Comments Remain Valid

Courtesy of Declan.

I don't want to overplay today's action as little changed in the broader scheme of things. Days like today are welcomed and help shape up swing trades for those trading in near term timeframes.

The tight doji in the S&P could be used for a swing trade; buy a break of the high/short loss of low - stop on flip side. High whipsaw risk but look for 3:1 risk:reward and maybe trail stops if deciding to go with partial profits.

Tech averages are still set up for a breakout. While not an ...

more from Chart School

Phil's Favorites

Spanish Government Fearmongering: "Catalonia Faces Brutal Impoverishment If Leave Wins"

Courtesy of Mish.

On October 1, Catalans head to the polls to vote yes or no on separation from Spain.

The Spanish government and constitutional court claim the referendum is illegal but 700 Catalonia mayors say the vote will take place.

Today Madrid launched a major fearmongering campaign: Catalonia Faces ‘Brutal’ Impoverishment If It Leave, Spain Warns.

“The general impoverishment of the society would be brutal. GDP could fall between 25 and 30 percent and unemployment double, ...

more from Ilene

Zero Hedge

Buildings Collapse, Thousands Take To The Street After Powerful Quake Shakes Mexico City

Courtesy of ZeroHedge. View original post here.

On the anniversary of a massive 1985 earthquake that killed at least 5,000 people, Mexico City has been shaken by another powerful earthquake, the second the shake the city in the past two weeks. Ironically, the quake occurred just two-hours after an earthquake drill. The 7.4 magnitude quake shook buildings in the capital city, sending thousands rushing into the streets, according to Reuters.


more from Tyler


FBN Beats CNBC Even During Delivering Alpha Week

By VWArticles. Originally published at ValueWalk.

Fox Business Network ratings for the week of September 11th – September  15th.  FBN beat CNBC even during their big annual Delivering Alpha Conference which is one of the biggest investment conferences of the year with Lou Dobbs leading the pack – another big win for FBN – see more details below


]]> Get The Full Ray Dalio Series in PDF

Get the entire 10-part series on Ray Dalio in PDF. Save it to your de...

more from ValueWalk

Insider Scoop

AMD, Marvell Gain Semiconductor Share In Q3

Courtesy of Benzinga.

Related AMD Fast Money Traders Share Their Picks In The Chip Space AMD, Bank Of America, Gilead, Intel: Fast Money Pic... more from Insider

Members' Corner

"Citron Exposes Ubiquiti Networks"

What do you think?


Does Ubiquiti Networks (NASDAQ:UBNT) actually have real products that sell to consumers? Of course! So did Valeant and WorldCom, but that does not stop its financials from having every indication of being completely fraudulent.

Citron will detail a series of alarming red flags and detail how Ubiquiti Networks is deceiving the investing public.

Read the full report here.


more from Our Members

Digital Currencies

Comparing Bitcoin, Ether, & Other Cryptos

Courtesy of Zero Hedge

Unless you’ve been hiding under a rock, you’re probably aware that we’re in the middle of a cryptocurrency explosion. In one year, the value of all currencies increased a staggering 1,466% – and newer coins like Ethereum have even joined Bitcoin in gaining some mainstream acceptance.

And while people like Jamie Dimon of J.P. Morgan and famed value investor Howard Marks have been extremely critical of cryptocurrencies as of late, many other investors are continuing to ride the wave. As Visual Capitalist's Jeff Desjardins has noted in the past, ...

more from Bitcoin


Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader


Can low doses of chemicals affect your health? A new report weighs the evidence

Reminder: Pharmboy and Ilene are available to chat with Members, comments are found below each post.


Can low doses of chemicals affect your health? A new report weighs the evidence

Courtesy of Rachel ShafferUniversity of Washington

Assessing the data. LightField Studios/

Toxicology’s founding father, Paracelsus, is famous for proclaiming that “...

more from Biotech

Mapping The Market

The App Economy Will Be Worth $6 Trillion in Five Years

Courtesy of Jean-Luc

This would be excellent news for AAPL and GOOG to a lesser extent although not inconsequential:

The App Economy Will Be Worth $6 Trillion in Five Years 

In five years, the app economy will be worth $6.3 trillion, up from $1.3 trillion last year, according to a report released today by app measurement company App Annie. What explains the growth? More people are spending more time and -- crucially -- more money in apps. While on average people aren't downloading many more apps, App Annie expects global app usership to nearly double to 6.3 billion people in the next five years while the time spent in apps will more than double. And, it expects the...

more from M.T.M.


NewsWare: Watch Today's Webinar!


We have a great guest at today's webinar!

Bill Olsen from NewsWare will be giving us a fun and lively demonstration of the advantages that real-time news provides. NewsWare is a market intelligence tool for news. In today's data driven markets, it is truly beneficial to have a tool that delivers access to the professional sources where you can obtain the facts in real time.

Join our webinar, free, it's open to all. 

Just click here at 1 pm est and join in!

[For more information on NewsWare, click here. For a list of prices: NewsWar...

more from Promotions

Kimble Charting Solutions

Brazil; Waterfall in prices starting? Impact U.S.?

Courtesy of Chris Kimble.

Below looks at the Brazil ETF (EWZ) over the last decade. The rally over the past year has it facing a critical level, from a Power of the Pattern perspective.


EWZ is facing dual resistance at (1), while in a 9-year down trend of lower highs and lower lows. The counter trend rally over the past 17-months has it testing key falling resistance. Did the counter trend reflation rally just end at dual resistance???

If EWZ b...

more from Kimble C.S.

All About Trends

Mid-Day Update

Reminder: Harlan is available to chat with Members, comments are found below each post.

Click here for the full report.

To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

FeedTheBull - Top Stock market and Finance Sites

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>